Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Special Report Awards Gala Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Special Report Awards Gala Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us CRO AIBioTech buys ImmunoTox; PPD adds an exec; By Damian Garde Mar 24, 2014 9:43am > Virgina's AIBioTech has purchased ImmunoTox, a CRO focused on immunotoxicology and immunopharmacology studies. More > PPD has appointed Biogen Idec ($BIIB) veteran Michael Pollock to serve as its vice president of real-world outcomes. Item